Mirum Pharmaceuticals, Inc. Stock Forecast
Evaluation of Mirum Pharmaceuticals, Inc. stock downgraded after the last trading session.
(Updated on Jun 25, 2024)
The Mirum Pharmaceuticals, Inc. stock price fell by -4.91% on the last day (Tuesday, 25th Jun 2024) from $34.85 to $33.14. During the last trading day the stock fluctuated 5.84% from a day low at $33.05 to a day high of $34.98. The price has risen in 6 of the last 10 days and is up by 29.71% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -358 thousand shares and in total, 854 thousand shares were bought and sold for approximately $28.30 million.
The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $34.92 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 13.57% during the next 3 months and, with a 90% probability hold a price between $28.51 and $39.66 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
MIRM Signals & Forecast
The Mirum Pharmaceuticals, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $31.34 and $26.52. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, June 24, 2024, and so far it has fallen -4.91%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Support, Risk & Stop-loss for Mirum Pharmaceuticals, Inc. stock
Mirum Pharmaceuticals, Inc. finds support from accumulated volume at $33.00 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $1.93 between high and low, or 5.84%. For the last week, the stock has had daily average volatility of 9.17%.
Our recommended stop-loss: $31.40 (-5.25%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 4 days ago.)
Trading Expectations (MIRM) For The Upcoming Trading Day Of Wednesday 26th
For the upcoming trading day on Wednesday, 26th we expect Mirum Pharmaceuticals, Inc. to open at $33.72, and during the day (based on 14 day Average True Range), to move between $31.21 and $35.07, which gives a possible trading interval of +/-$1.93 (+/-5.83%) up or down from last closing price. If Mirum Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 11.66% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $33.00 (0.42%) than the resistance at $34.85 (5.16%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Mirum Pharmaceuticals, Inc. stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Mirum Pharmaceuticals, Inc. stock to perform well in the short-term. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Buy candidate.
Current score: 2.597 Buy Candidate Downgraded
Predicted Opening Price for Mirum Pharmaceuticals, Inc. of Wednesday, June 26, 2024
| Fair opening price June 26, 2024 | Current price |
|---|---|
| $33.72 ( 1.76%) | $33.14 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for MIRM
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 35.65 | 7.58% |
| R2 | 34.92 | 5.36% |
| R1 | 34.46 | 3.98% |
| Price | 33.14 | |
| S1 | 32.99 | -0.464% |
| S2 | 32.53 | -1.84% |
| S3 | 31.79 | -4.06% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0 | - |
| R2 | 0 | - |
| R1 | 34.85 | 5.16% |
| Price | 33.14 | |
| S1 | 33.00 | -0.422% |
| S2 | 32.05 | -3.29% |
| S3 | 29.25 | -11.74% |
FAQ
Click here for our free guide on how to buy Mirum Pharmaceuticals, Inc. Stock.
